Impact of Prior Bendamustine Exposure on Bispecific Antibody Outcomes in Relapsed/Refractory Follicular Lymphoma
Blood Adv. 2026 Jan 7:bloodadvances.2025018546. doi: 10.1182/bloodadvances.2025018546.…
Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia
Antimicrob Agents Chemother. 2025 Nov 25:e0125325. doi: 10.1128/aac.01253-25.…
Neglected tropical diseases (NTDs) and related infections in hematopoietic cellular therapy (HCT) in adults and children: a survey from the Infectious Diseases Working Party (IDWP) of the European Society of Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplant. 2025 Nov 22. doi: 10.1038/s41409-025-02767-z.…
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe
Cytotherapy. 2025 Sep 23:101984. doi: 10.1016/j.jcyt.2025.09.007.…
Use of bone marrow cells is associated with improved outcomes when compared to peripheral blood stem cell after haplo-identical transplants with post transplant cyclophosphamide, a study from of the CTIWP-EBMT
Bone Marrow Transplant. 2025 Nov 5. doi: 10.1038/s41409-025-02735-7.…
Operational burden and fragmented implementation in CAR T-cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee
Hemasphere. 2025 Oct 27;9(10):e70243. doi: 10.1002/hem3.70243.…
Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial
J Clin Oncol. 2025 Oct 20:JCO2500992. doi: 10.1200/JCO-25-00992.…
Specific targeting of the pseudogene RPSAP52 reduces ovarian tumor growth in patient-derived orthoxenograft models
Eur J Cancer. 2025 Oct 3;230:116040. doi: 10.1016/j.ejca.2025.116040.…
Impact of the national blackout of April 28, 2025 on processing facilities for hematopoietic stem cell transplantation and cell therapy in Spain
Transfus Apher Sci. 2025 Sep 30;64(6):104257. doi: 10.1016/j.transci.2025.104257.…
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
Bone Marrow Transplant. 2025 Oct 1. doi: 10.1038/s41409-025-02696-x.…
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G Committee
J Eur Acad Dermatol Venereol. 2025 Oct 1. doi: 10.1111/jdv.70042.…
Enhancing myeloablative fludarabine-busulfan conditioning with total marrow irradiation in high-risk myeloid disease
Haematologica. 2025 Sep 25. doi: 10.3324/haematol.2025.288307.…
